Try our Advanced Search for more refined results
Mergers & Acquisitions
-
October 27, 2025
KKR, Apollo Plug $7B Into Beverage Biz Keurig Dr Pepper
Beverage giant Keurig Dr Pepper on Monday revealed it has secured additional strategic investments for a planned $18.4 billion acquisition of JDE Peet's, with private equity giants KKR, advised by Kirkland & Ellis LLP, and Apollo Global Management, led by Latham & Watkins LLP, plugging $7 billion into the drink company.
-
October 27, 2025
Holland & Knight's CFIUS Team Leader Jumps To Weil
The leader of Holland & Knight LLP's Committee on Foreign Investment in the United States and industrial security team has made the move to Weil Gotshal & Manges LLP in Washington, D.C., the firm announced Monday.
-
October 27, 2025
Trian, General Catalyst Make $7.2B Play For Janus Henderson
Janus Henderson Group said Monday it has received a $7.2 billion buyout offer from Trian Fund Management LP and General Catalyst Group Management LLC, which say the British asset management firm could more effectively achieve its goals as a private company.
-
October 27, 2025
Catching Up With Delaware's Chancery Court
The Delaware Chancery Court and Delaware Supreme Court saw another busy week of disputes spanning biotech milestones, reincorporation showdowns, shareholder voting schemes and cryptocurrency fiduciary rights.
-
October 27, 2025
Compass Pushes For Redfin Docs In Zillow Antitrust Fight
Compass Inc. has urged a New York federal court presiding over the brokerage's antitrust suit against property listings company Zillow Inc. to order another property listings company, Redfin Corp., to provide copies of drafts of blog posts written by Redfin's CEO as well as a copy of an allegedly anticompetitive Zillow-Redfin rental agreement.
-
October 27, 2025
Top FTC Atty In Meta And Amazon Cases Joins WilmerHale
A former chief trial counsel at the Federal Trade Commission's Bureau of Competition, who was one of the lead attorneys on the agency's landmark monopolization cases against Amazon and Meta, has joined WilmerHale's Washington, D.C. office, the firm announced Monday.
-
October 27, 2025
Paul Weiss, K&L Gates Lead $660M Albemarle, Ketjen Deals
K&L Gates LLP-advised Albemarle Corp. on Monday announced that it has agreed to sell a majority stake in Ketjen Corp.'s refining catalyst solutions business to Paul Weiss Rifkind Wharton & Garrison LLP-led private equity shop KPS Capital Partners, and separately announced it will sell a 50% interest in a joint venture with Ketjen to Axens SA in two deals that will provide the company with pre-tax proceeds of around $660 million.
-
October 27, 2025
Schroders Portfolio Biz Agrees Sale To Data Co. For $1.7B
Schroders Capital Global Innovation Trust PLC said Monday that its portfolio company, Securiti AI, has signed an agreement to be acquired by private equity-backed business Veeam Software for approximately $1.7 billion.
-
October 27, 2025
Wachtell-Led Huntington Strikes $7.4B Deal For Cadence Bank
Huntington Bancshares Inc. said Monday it has agreed to acquire Cadence Bank for $7.4 billion in one of the top banking sector deals of 2025, with Wachtell Lipton advising Huntington and Sullivan & Cromwell guiding Cadence.
-
October 27, 2025
UK Raises Antitrust Concern Over £1.2B Greencore Deal
The Competition and Markets Authority said on Monday that Greencore's planned £1.2 billion ($1.6 billion) deal for meals producer Bakkavor might harm competition in the U.K.'s market for chilled sauces.
-
October 27, 2025
Covington Helps Novartis Buy Avidity Biosciences For $12B
Swiss pharmaceutical giant Novartis AG has said it will buy Avidity Biosciences, a U.S. developer of therapeutics for muscle diseases, for approximately $12 billion in a move to boost its neuroscience portfolio.
-
October 26, 2025
7 Firms Steer $2.1B Take-Private Deal For Plymouth REIT
Real estate investment firm Makarora Management LP and Ares Management Corp. have agreed to acquire and take private Plymouth Industrial REIT Inc. in a $2.1 billion cash deal guided by seven law firms, coming three months after a competing buyout offer for Plymouth.
-
October 24, 2025
JPMorgan Accuses Charlie Javice Of 'Abusive' Atty Fee Billing
JPMorgan Chase & Co. on Friday asked a Delaware state judge to reverse a 2023 order requiring the bank to cover the legal fees of convicted Frank founder Charlie Javice, arguing that the court must put a stop to her "abusive billing."
-
October 24, 2025
X Corp. Says Ex-Twitter Workers' Bid Is Too Little, Too Late
Elon Musk's X Corp. told a Delaware federal judge that six former Twitter workers' bid to revive their dismissed severance claims by raising fresh contract theories and stale arbitration testimony is "far too little, far too late."
-
October 24, 2025
Avalara Investors Fight Stay In $8.4B Buyout Dispute
Shareholders of tax software company Avalara are fighting a motion by the company in Washington federal court to stay litigation accusing it of misleading investors ahead of an $8.4 billion deal to take the company private.
-
October 24, 2025
Off The Bench: NBA Gambling Woes, Golfer's $50M Trial Win
In this week's Off The Bench, the NBA faces a gambling scandal during its opening week, a Florida jury hands golfer Jack Nicklaus a $50 million victory in his defamation lawsuit, and DraftKings and the NHL step into the realm of prediction markets.
-
October 24, 2025
Sterlington Founder Talks C-Suite Guidance After $40B Deal
On the heels of representing Aligned Data Centers' management in the company's $40 billion sale, Sterlington PLLC founder Chris Harrison spoke with Law360 about fundamental changes reshaping negotiations with buyers as private equity strategies evolve.
-
October 24, 2025
Paris-Based SPAC Targets US Acquisition After Raising $100M
French special purpose acquisition company LaFayette Acquisition Corp. began trading publicly on Friday after raising $100 million in its U.S. initial public offering, with plans to target U.S. companies in a range of industries.
-
October 24, 2025
RunItOneTime Tells Judge Debtor In Talks For More DIP Cash
RunItOneTime LLC told a Texas bankruptcy judge on Friday it is in talks with its post-petition financing lender for more funds as it prepares to face the loss of operating cash from assets subject to sales the debtor hopes to close.
-
October 24, 2025
Eli Lilly Buying Eye Disease Biotech For Up To $262M
Ropes & Gray LLP-advised Eli Lilly said Friday it has agreed to acquire Cooley LLP-guided Adverum Biotechnologies, a clinical-stage company developing gene therapies for eye diseases, for up to roughly $262 million.
-
October 24, 2025
Taxation With Representation: Latham, Wachtell, Gibson Dunn
In this week's Taxation With Representation, Meta announces a joint venture with Blue Owl Capital to fund the development of a data center campus in Louisiana, private equity giants acquire medical technology company Hologic Inc., and National Fuel Gas Co. buys CenterPoint Energy Inc.'s Ohio natural gas utility business.
-
October 24, 2025
CMA Concerned Over Aramark Deal For Scottish Catering Co.
Britain's antitrust enforcer has clarified its concerns with Aramark Group's completed acquisition of Scottish catering company Entier Ltd. over the supply of catering and related services for the offshore energy sector.
-
October 24, 2025
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen the Financial Conduct Authority launch legal action against a Chinese cryptocurrency exchange, The Londoner magazine face a defamation claim from an entrepreneur accused of "scamming" Knightsbridge landlords, and Gucci sued by its cosmetics supplier as L'Oréal announces plans to buy the Italian fashion house's beauty brand. Here, Law360 looks at these and other new claims in the U.K.
-
October 24, 2025
Warburg Pincus, Permira Get More Time To Bid For JTC
Professional services provider JTC said Friday that the takeover panel has given two separate private equity firms an extension to table formal offers to acquire the professional services or walk away.
-
October 23, 2025
Chancery Maps Out Math For Hefty Drug Co. Breach Interest
A Delaware vice chancellor late Thursday issued a road map for calculating tens of millions of dollars in interest due after a ruling in June that Alexion Pharmaceuticals failed a "best efforts" duty to fulfill an autoimmune drug candidate deal with Syntimmune Inc.
Expert Analysis
-
Nev. Steps Up Efforts To Attract Incorporations With New Law
Recent amendments to Nevada corporate law, which will narrow controlling stockholders’ liability, streamline mergers and allow companies to opt out of jury trials, show the interstate competition to attract new and reincorporating companies is still heating up, say attorneys at Simpson Thacher.
-
ABA Opinion Makes It A Bit Easier To Drop A 'Hot Potato'
The American Bar Association's recent ethics opinion clarifies when attorneys may terminate clients without good cause, though courts may still disqualify a lawyer who drops a client like a hot potato, so sending a closeout letter is always a best practice, say attorneys at Thompson Hine.
-
Plan For Increased HSR Info Sharing With Wash. Antitrust Law
Washington's merger notification requirements, effective later this month, combined with the Federal Trade Commission's new Hart-Scott-Rodino Act rules, will result in greater information sharing among state and federal agencies, making it important for merging parties to consider their transaction's potential state antitrust implications early on, say attorneys at McDermott.
-
Dupes Boom Spurs IP Risks, Opportunities For Investors
The rising popularity of dupe products has created a dynamic marketplace where both dupes-based businesses and established branded companies can thrive, but investors must consider a host of legal implications, especially when the dupes straddle a fine line between imitation and intellectual property infringement, say attorneys at Ropes & Gray.
-
How Trump's Trade Policies Are Shaping Foreign Investment
Five months into the Trump administration, investors are beginning to see the concrete effects of the president’s America First Investment Policy as it presents new opportunities for clearing transactions more quickly, while sustaining risk aversion related to Chinese trade and potentially creating different political risks, say attorneys at Covington.
-
Series
My Opera And Baseball Careers Make Me A Better Lawyer
Though participating in opera and the world of professional baseball often pulls me away from the office, my avocations improve my legal career by helping me perform under scrutiny, prioritize team success, and maintain joy and perspective at work, says Adam Unger at Herrick Feinstein.
-
FTC Focus: Enforcers Study AI Innovation And Entrenchment
The Federal Trade Commission and other regulators setting their sights on the burgeoning artificial intelligence ecosystem are considering how the government should approach innovation in tech markets that tend, almost inevitably, toward concentration, say attorneys at Proskauer.
-
8 Ways Lawyers Can Protect The Rule Of Law In Their Work
Whether they are concerned with judicial independence, regulatory predictability or client confidence, lawyers can take specific meaningful actions on their own when traditional structures are too slow or too compromised to respond, says Angeli Patel at the Berkeley Center of Law and Business.
-
Assessing New Changes To Texas Officer Exculpation Law
Consistent with Texas' recent modernization of its corporate law, the recently passed S.B. 2411 allows officer exculpation, streamlines certificate of formation amendments, authorizes representatives to act on shareholders' behalf in mergers and makes other changes aimed toward companies seeking a more codified, statutory model of corporate governance, say attorneys at Bracewell.
-
Series
Law School's Missed Lessons: Communicating With Clients
Law school curricula often overlook client communication procedures, and those who actively teach this crucial facet of the practice can create exceptional client satisfaction and success, says Patrick Hanson at Wiggam Law.
-
Series
Adapting To Private Practice: From US Rep. To Boutique Firm
My transition from serving as a member of Congress to becoming a partner at a boutique firm has been remarkably smooth, in part because I never stopped exercising my legal muscles, maintained relationships with my former colleagues and set the right tone at the outset, says Mondaire Jones at Friedman Kaplan.
-
Spinoff Transaction Considerations For Biotech M&A
Amid current market challenges, boards and management teams of biotech companies can consider several strategies for maximizing value should a spinoff opportunity arise, but not without significant advance planning and careful implementation, particularly in cases that might qualify as tax-free, say attorneys at Paul Hastings.
-
Opinion
Senate's 41% Litigation Finance Tax Would Hurt Legal System
The Senate’s latest version of the Big Beautiful Bill Act would impose a 41% tax on the litigation finance industry, but the tax is totally disconnected from the concerns it purports to address, and it would set the country back to a time when small plaintiffs had little recourse against big defendants, says Anthony Sebok at Cardozo School of Law.
-
Series
Performing As A Clown Makes Me A Better Lawyer
To say that being a clown in the Macy’s Thanksgiving Day Parade has changed my legal career would truly be an understatement — by creating an opening to converse on a unique topic, it has allowed me to connect with clients, counsel and even judges on a deeper level, says Charles Tatelbaum at Tripp Scott.
-
Series
Law School's Missed Lessons: Rejecting Biz Dev Myths
Law schools don’t spend sufficient time dispelling certain myths that prevent young lawyers from exploring new business opportunities, but by dismissing these misguided beliefs, even an introverted first-year associate with a small network of contacts can find long-term success, says Ronald Levine at Herrick Feinstein.